Cargando…
Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis
OBJECTIVES: High-dose glucocorticoids are associated with improved recovery of deficits in primary autoimmune hypophysitis (PAH), but optimal dosing, route, and duration are unclear. DESIGN: We reviewed literature for first-line glucocorticoid treatment in PAH until December 2021 and performed an in...
Autores principales: | Krishnappa, Brijesh, Shah, Ravikumar, Memon, Saba Samad, Diwaker, Chakra, Lila, Anurag R, Patil, Virendra A, Shah, Nalini S, Bandgar, Tushar R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874965/ https://www.ncbi.nlm.nih.gov/pubmed/36445257 http://dx.doi.org/10.1530/EC-22-0311 |
Ejemplares similares
-
Abstract 70: High dose intravenous therapy augments complete anterior pituitary hormoanl recovery in primary autoimmune hypophysitis
por: Brijesh, K, et al.
Publicado: (2022) -
Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease
por: Diwaker, Chakra, et al.
Publicado: (2022) -
Exonic WT1 pathogenic variants in 46,XY DSD associated with gonadoblastoma
por: Arya, Sneha, et al.
Publicado: (2021) -
Low-Dose, Low-Specific Activity (131)I-metaiodobenzyl Guanidine Therapy in Metastatic Pheochromocytoma/Sympathetic Paraganglioma: Single-Center Experience from Western India
por: Barnabas, Rohit, et al.
Publicado: (2021) -
(177)Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma
por: Kumar Jaiswal, Sanjeet, et al.
Publicado: (2020)